rs137852436
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The ENST00000360256.9(F8):c.2167G>A(p.Ala723Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000273 in 1,097,863 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A723D) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000360256.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.2167G>A | p.Ala723Thr | missense_variant | 14/26 | ENST00000360256.9 | NP_000123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.2167G>A | p.Ala723Thr | missense_variant | 14/26 | 1 | NM_000132.4 | ENSP00000353393 | P1 | |
F8 | ENST00000647125.1 | c.*1833G>A | 3_prime_UTR_variant, NMD_transcript_variant | 14/14 | ENSP00000496062 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000550 AC: 1AN: 181821Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67031
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1097863Hom.: 0 Cov.: 32 AF XY: 0.00000551 AC XY: 2AN XY: 363295
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:4
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1995 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 17, 2024 | Variant summary: F8 c.2167G>A (p.Ala723Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 181821 control chromosomes. c.2167G>A has been reported in the literature in multiple individuals affected with mild/moderate Hemophilia A (example: Cygan_2016). These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 27704658). ClinVar contains an entry for this variant (Variation ID: 10246). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Feb 23, 2023 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.84; 3Cnet: 0.63). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000010246 / PMID: 1908096). A different missense change at the same codon (p.Ala723Val) has been reported to be associated with F8 related disorder (PMID: 25854144). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 25, 2019 | The F8 c.2167G>A (p.Ala723Thr) variant, which was also previously referred to as p.Ala704Thr, is a missense variant. Across a selection of the available literature, it has been identified in at least four unrelated individuals with mild-to-moderate hemophilia A (Higuchi et al. 1991; Antonarakis et al. 1995; Inaba et al. 2013). For three cases, factor VIII activity was reported as falling within 2-29%. In the fourth case, the lowest FVIII:C level was recorded clinically was 0.034 IU/mL. This variant is reported at a frequency of 0.000053 in the South Asian population of the Genome Aggregation Database, where it is found on a single hemizygous allele. Coverage of this genomic region is good, suggesting the variant is rare. In addition, multiple in silico algorithms predict the variant, which is located in the F5/8 type A2 domain, to have a deleterious effect. Based on this evidence and application of the ACMG criteria, the p.Ala723Thr variant is classified as pathogenic for hemophilia A, FVIII deficiency. - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 24, 2023 | The F8 c.2167G>A; p.Ala723Thr variant (rs137852436), also known as Ala704Thr, has been reported in multiple individuals diagnosed with mild to moderate hemophilia A (see link to FVIII database and references therein, Higuchi 1991, Markoff 2009). The variant is reported in the ClinVar database (Variation ID: 10246) and is observed on only 1 allele in the Genome Aggregation Database, indicating it is not a common polymorphism. The alanine at codon 723 is highly conserved, and additional variants at this position (c.2168C>A; p.Ala723Asp and c.2168C>T; p.Ala723Val) have been described in individuals with hemophilia A and are considered pathogenic (see link to FVIII database and references therein). Based on available information, the p.Ala723Thr variant is considered pathogenic. References: Link to Factor VIII variant database: http://www.factorviii-db.org/ Higuchi M et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7405-9. Markoff A et al. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Haemophilia. 2009 Jul;15(4):932-41. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 27, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22883072, 31064749, 27380589, 19473423, 27704658, 18691168, 8547094, 15625837, 11857744, 16972227, 24845853, 23625609, 21645180, 23711237, 11179760, 20331761, 23617593, 32224444, 25550078, 1908096, 9452104, 15921397, 29296726, 33245802, 33706050, 32897612) - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 04, 2024 | PP1_strong, PP3, PM1, PM2, PM6, PS4_moderate - |
Hereditary factor VIII deficiency disease;C5676879:Thrombophilia, X-linked, due to factor 8 defect Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 07, 2022 | - - |
Hereditary factor IX deficiency disease Pathogenic:1
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Feb 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at